# U.S. Animal Health Market Expands

The U.S. animal health market is projected to nearly double from USD 20.92 billion in 2025 to USD 47.65 billion by 2034, driven by rising pet ownership, increasing livestock disease challenges, and advances in veterinary diagnostics and biologicals. This growth signals expanding procurement opportunities for government agencies and contractors involved in pharmaceuticals, diagnostics, and vaccine development for animal health across key U.S. regions including the Midwest, South, West, and Northeast.

- **Why this matters:** Procurement professionals should anticipate increased demand for innovative veterinary products and services, creating opportunities for contract awards and partnerships with leading industry players such as Zoetis Services LLC, Merck & Co. Inc., Elanco, and Boehringer Ingelheim International GmbH.
- Agencies involved in animal health and agricultural biosecurity may need to update acquisition strategies to incorporate novel vaccine platforms and advanced diagnostic technologies.
- Companies specializing in animal health pharmaceuticals and diagnostics should consider targeting regional government contracts, especially in major U.S. regions and hubs like Parsippany, New Jersey.
- Procurement teams can leverage this market growth to support livestock disease management programs and pet health initiatives, aligning with broader public health and agricultural objectives.

**Jurisdictions:** federal
**Industries:** Healthcare, Energy & Utilities
**Topics:** Grants & Funding, Regulatory Compliance
**Published:** September 25, 2026

### Vendors
- Zoetis Services LLC (key player)
- Merck & Co. Inc. (key player)
- Elanco ()
- Boehringer Ingelheim International GmbH ()

### Sources
- [United States Animal Health Market Size Projected to Reach USD](https://www.openpr.com/news/4643877/united-states-animal-health-market-size-projected-to-reach-usd) - openpr.com